We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
-0.26%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$102B
AUM Growth
-$731M
(-0.71%)
Cap. Flow
+$803M
Cap. Flow
% of AUM
0.79%
Top 10 Holdings %
Top 10 Hldgs %
35.47%
Holding
263
New
6
Increased
107
Reduced
91
Closed
3
Avg Time Held
1.7
years
Top 10 Avg Time Held
1.9
years
Top 20 Avg Time Held
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$347M |
| 2 |
JPMorgan Chase
JPM
|
+$285M |
| 3 |
NetApp
NTAP
|
+$279M |
| 4 |
TRCO
TRIBUNE MEDIA COMPANY CLASS A
TRCO
|
+$225M |
| 5 |
HP
HPQ
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$585M |
| 2 |
CME Group
CME
|
+$258M |
| 3 |
Honeywell
HON
|
+$194M |
| 4 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$131M |
| 5 |
Intuit
INTU
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.73% |
| 2 | Technology | 26.95% |
| 3 | Industrials | 13.36% |
| 4 | Consumer Discretionary | 8.68% |
| 5 | Miscellaneous | 6.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
AFFX
126
DELISTED
Affymetrix Inc
AFFX
| $120M | 0.12% |
11,014,740
-22,300
| -0.2% | -$270K |
2013 Q2
8 quarters
|
|
127
Rambus
RMBS
$10.1B
| $120M | 0.12% |
8,291,622
-50,650
| -0.6% | -$724K |
2013 Q2
8 quarters
|
|
128
Merck
MRK
$358B
| $116M | 0.11% |
2,140,016
+688,536
| +47% | +$38.6M |
2014 Q4
2 quarters
|
|
129
IDEX
IEX
$17.4B
| $115M | 0.11% |
1,461,505
+24,805
| +2% | +$1.92M |
2013 Q2
8 quarters
|
|
130
Charles River Laboratories
CRL
$14.6B
| $114M | 0.11% |
1,622,300
| – | – |
2013 Q2
8 quarters
|
|
|
NBL
131
DELISTED
Noble Energy, Inc.
NBL
| $113M | 0.11% |
2,648,800
-658,300
| -20% | -$31.1M |
2013 Q2
8 quarters
|
|
132
Applied Materials
AMAT
$341B
| $112M | 0.11% |
5,808,355
+113,900
| +2% | +$2.34M |
2013 Q2
8 quarters
|
|
133
Standard BioTools
LAB
$258M
| $98.5M | 0.1% |
4,069,132
+343,300
| +9% | +$10.8M |
2013 Q2
8 quarters
|
|
134
Urban Outfitters
URBN
$7.49B
| $96M | 0.09% |
2,744,256
+138,450
| +5% | +$5.36M |
2014 Q3
3 quarters
|
|
135
MarketAxess Holdings
MKTX
$5.79B
| $93.1M | 0.09% |
1,003,420
| – | – |
2013 Q2
8 quarters
|
|
136
Norfolk Southern
NSC
$73B
| $92.7M | 0.09% |
1,060,980
+64,900
| +7% | +$6.32M |
2013 Q2
8 quarters
|
|
137
Curtiss-Wright
CW
$18.5B
| $91.9M | 0.09% |
1,269,250
-595,024
| -32% | -$43.9M |
2013 Q3
7 quarters
|
|
138
DELISTED
Sprint Corporation
S
| $91.6M | 0.09% |
20,085,000
+3,520,000
| +21% | +$16.9M |
2014 Q3
3 quarters
|
|
139
Waters Corp
WAT
$43.6B
| $91.4M | 0.09% |
711,722
-261,889
| -27% | -$34M |
2013 Q2
8 quarters
|
|
140
Mastercard
MA
$540B
| $90.4M | 0.09% |
967,550
+14,800
| +2% | +$1.36M |
2013 Q2
8 quarters
|
|
141
Celanese
CE
$5.1B
| $88.5M | 0.09% |
1,231,100
+229,000
| +23% | +$15.2M |
2013 Q2
8 quarters
|
|
142
DuPont de Nemours
DD
$17.8B
| $88M | 0.09% |
679,196
+9,438
| +1% | +$1.22M |
2013 Q2
8 quarters
|
|
143
Jabil
JBL
$30.1B
| $86.7M | 0.09% |
4,072,200
+143,175
| +4% | +$3.38M |
2013 Q2
8 quarters
|
|
144
DELISTED
Coterra Energy
CTRA
| $84.8M | 0.08% |
2,688,200
+73,000
| +3% | +$2.44M |
2013 Q2
8 quarters
|
|
|
FEIC
145
DELISTED
FEI COMPANY
FEIC
| $83.6M | 0.08% |
1,008,200
| – | – |
2013 Q2
8 quarters
|
|
146
NOV
NOV
$6.64B
| $81.7M | 0.08% |
1,692,545
-85,205
| -5% | -$4.38M |
2013 Q2
8 quarters
|
|
147
Herc Holdings
HRI
$4.15B
| $80.1M | 0.08% |
1,472,933
+126,133
| +9% | +$7.8M |
2013 Q2
8 quarters
|
|
148
Descartes Systems
DSGX
$7.58B
| $79.7M | 0.08% |
4,963,090
-9,100
| -0.2% | -$141K |
2013 Q2
8 quarters
|
|
149
DELISTED
Faro Technologies
FARO
| $79.2M | 0.08% |
1,696,000
+2,400
| +0.1% | +$113K |
2013 Q2
8 quarters
|
|
150
DELISTED
Exact Sciences
EXAS
| $78.3M | 0.08% |
2,631,300
+105,000
| +4% | +$2.64M |
2014 Q2
4 quarters
|
|
Similar funds
Primecap Management's Q2 2015 Portfolio in Review
As of Q2 2015, Primecap Management held 263 positions worth $102B, down 0.71% from $102B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Trading was light in Q2 2015: portfolio turnover was 3.4%. Primecap Management opened 6 new positions and exited 3, leaving the 263-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 28% a quarter earlier, followed by Technology and Industrials.
- Primecap Management's largest Q2 2015 buy was Pfenex Inc.: 2,371,388 shares worth $46M.
- Primecap Management added most to Alibaba in Q2 2015, an estimated $347M increase.
- Primecap Management's biggest Q2 2015 reduction was CME Group, cutting an estimated $258M.
- Primecap Management fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $585M.
- Primecap Management's ten largest holdings make up 35% of its $102B portfolio in Q2 2015.
- Primecap Management opened 6 new positions and closed 3 in Q2 2015.
- Primecap Management's portfolio value fell 0.71% quarter-over-quarter to $102B.
Based on Primecap Management's 13F filing for Q2 2015, filed 13 Aug 2015.